FDA clears Ocelot catheter for PAD

The FDA has cleared Avinger’s Ocelot System, an interventional chronic total occlusion crossing catheter, for sale in the U.S. The system is used to treat patients with peripheral artery disease (PAD).

The Ocelot catheter offers intravascular imaging technology through optical coherence tomography, which allows physicians to cross, see and navigate inside blocked arteries in legs of patients with PAD. The Ocelot catheter is supported by the Lightbox console.

According to Redwood City, Calif.-based Avinger, the FDA reviewed results from the Ocelot CONNECT II trial, which included 122 patients in the U.S.

 

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup